Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Feuerstein

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: inflammatory bowel disease guidelines and conflicts of interest--authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
Alimentary Pharmacology & Therapeutics|July 2, 2013
Letter: international IBD practice guidelines -- authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
Journal of Crohn'S & Colitis|July 23, 2014
A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndromeJ D Feuerstein, S N Flier, E U Yee, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2013
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelinesJ D Feuerstein, M Akbari, A E Gifford, et al.
The American Journal of Gastroenterology|December 17, 2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective studyN Sengupta, J D Feuerstein, V R Patwardhan, et al.
The American Journal of Gastroenterology|March 7, 2015
Erratum: the risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective studyN Sengupta, J D Feuerstein, V R Patwardhan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: inflammatory bowel disease guidelines and conflicts of interest--authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
Alimentary Pharmacology & Therapeutics|July 2, 2013
Letter: international IBD practice guidelines -- authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
Journal of Crohn'S & Colitis|July 23, 2014
A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndromeJ D Feuerstein, S N Flier, E U Yee, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2013
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelinesJ D Feuerstein, M Akbari, A E Gifford, et al.
The American Journal of Gastroenterology|December 17, 2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective studyN Sengupta, J D Feuerstein, V R Patwardhan, et al.
The American Journal of Gastroenterology|March 7, 2015
Erratum: the risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective studyN Sengupta, J D Feuerstein, V R Patwardhan, et al.
Pageof 1